financetom
Business
financetom
/
Business
/
Eastman Chemical Q2 Adjusted Earnings, Revenue Rise; 2024 EPS Range Outlook Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eastman Chemical Q2 Adjusted Earnings, Revenue Rise; 2024 EPS Range Outlook Narrows
Jul 25, 2024 2:20 PM

04:57 PM EDT, 07/25/2024 (MT Newswires) -- Eastman Chemical ( EMN ) reported Q2 adjusted earnings late Thursday of $2.15 per diluted share, up from $1.99 per share a year earlier.

Analysts polled by Capital IQ expected $2.01.

Revenue for the quarter ended June 30 rose to $2.36 billion from $2.32 billion a year earlier. Analysts surveyed by Capital IQ expected $2.35 billion.

The company narrowed its 2024 EPS outlook to $7.40 to $7.85 from $7.25 to $8. The consensus is for $7.68 normalized.

Price: 99.35, Change: +2.21, Percent Change: +2.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates
Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates
Nov 3, 2024
08:19 AM EDT, 10/28/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that results from a phase 3 study of Tremfya as a treatment for Crohn's disease showed high remission rates among tested patients. The first 12 weeks of the trial where Tremfya was administered subcutaneously showed that 56.1% of treated patients achieved clinical remission, J&J said....
Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers
Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers
Nov 3, 2024
08:20 AM EDT, 10/28/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately. Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the...
HF Foods Group Appoints COO Felix Lin as Interim CEO
HF Foods Group Appoints COO Felix Lin as Interim CEO
Nov 3, 2024
08:20 AM EDT, 10/28/2024 (MT Newswires) -- HF Foods Group ( HFFG ) said Monday it appointed Chief Operating Officer Felix Lin as interim chief executive to succeed Peter Zhang. The company said the change in leadership is not due to any disagreement with Zhang, who will remain on the board of directors. No further details on Zhang's departure from...
Atlas Lithium Receives Approval for Brazil Lithium Mining, Processing Operations
Atlas Lithium Receives Approval for Brazil Lithium Mining, Processing Operations
Nov 3, 2024
08:19 AM EDT, 10/28/2024 (MT Newswires) -- Atlas Lithium ( ATLX ) said Monday it has received an operational permit from the Brazilian state of Minas Gerais for the Neves lithium-mining project. With the approval, Atlas has the necessary permits to assemble and operate a lithium processing plant and pursue open-pit mining at one of its deposits. The approval, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved